Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Kenney

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|August 11, 2007
3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic strokeRobert K Kosior, Caitlin J Wright, Jayme C Kosior, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Tissue Window in Stroke Thrombolysis study (TWIST): a safety studyMichael D Hill, Carol Kenney, Imanuel Dzialowski, et al.
Journal of Clinical Epidemiology|April 26, 2026
Justification of Deferral of Consent in the ACT-GLOBAL Adaptive Platform Trial in StrokeMichel Shamy, Nishita Singh, Aravind Ganesh, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 27, 2025
Patient and Caregiver Perspectives on the Design and Execution of ACT-GLOBAL, a Stroke Adaptive Platform Trial: A Focus Group StudyAravind Ganesh, Nora D Cristall, Brian Dewar, et al.
Stroke|May 23, 2022
Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic StrokeHannah Faris, Brian Dewar, Dar Dowlatshahi, et al.
Stroke|February 14, 2015
Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusionShelagh B Coutts, Véronique Dubuc, Jennifer Mandzia, et al.
Neurology|November 7, 2024
Consent-Related Outcomes in the Alteplase Compared to Tenecteplase TrialMichel C Shamy, Brian Dewar, Yan Deschaintre, et al.
CMAJ Open|June 19, 2021
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trialIlan Schwartz, Mari E Boesen, Graziela Cerchiaro, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Understanding Physician and Patient Preferences for Thrombolysis in Ischemic Stroke Eligible for Endovascular ThrombectomyNishita Singh, Nima Kashani, Aravind Ganesh, et al.
Stroke (Hoboken, N.J.)|May 8, 2026
AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical TrialTolulope Sajobi, Nishita Singh, Mohammed A Almekhlafi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cerebrovascular Diseases (Basel, Switzerland)|August 11, 2007
3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic strokeRobert K Kosior, Caitlin J Wright, Jayme C Kosior, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Tissue Window in Stroke Thrombolysis study (TWIST): a safety studyMichael D Hill, Carol Kenney, Imanuel Dzialowski, et al.
Journal of Clinical Epidemiology|April 26, 2026
Justification of Deferral of Consent in the ACT-GLOBAL Adaptive Platform Trial in StrokeMichel Shamy, Nishita Singh, Aravind Ganesh, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 27, 2025
Patient and Caregiver Perspectives on the Design and Execution of ACT-GLOBAL, a Stroke Adaptive Platform Trial: A Focus Group StudyAravind Ganesh, Nora D Cristall, Brian Dewar, et al.
Stroke|May 23, 2022
Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic StrokeHannah Faris, Brian Dewar, Dar Dowlatshahi, et al.
Stroke|February 14, 2015
Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusionShelagh B Coutts, Véronique Dubuc, Jennifer Mandzia, et al.
Neurology|November 7, 2024
Consent-Related Outcomes in the Alteplase Compared to Tenecteplase TrialMichel C Shamy, Brian Dewar, Yan Deschaintre, et al.
CMAJ Open|June 19, 2021
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trialIlan Schwartz, Mari E Boesen, Graziela Cerchiaro, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Understanding Physician and Patient Preferences for Thrombolysis in Ischemic Stroke Eligible for Endovascular ThrombectomyNishita Singh, Nima Kashani, Aravind Ganesh, et al.
Stroke (Hoboken, N.J.)|May 8, 2026
AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical TrialTolulope Sajobi, Nishita Singh, Mohammed A Almekhlafi, et al.
Pageof 2